Stock News•1 day ago
What Evolus (EOLS) Said on Its Q3 Earnings Call
Evolus reported Q3 revenue of $78M, up 13% YoY, driven by injectable product sales growth, and posted its fourth consecutive quarter of positive adjusted EBITDA.
MarketLens
Is Evolus (EOLS) Finally Turning the Corner on Profitability
6 months ago
SHARE THIS ON:
Exclusive Content for Pro Members
Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.
SHARE THIS ON:
Related Articles
Category
You may also like
Stock News•2 weeks ago
Establishment Labs Holdings Inc. (ESTA) Expected to Beat Earnings Estimates: Should You Buy?
Establishment Labs (ESTA) is expected to beat upcoming earnings estimates, based on a favorable combination of two key factors, though specific figures and timing were not disclosed.
News•1 months ago
InnovAge: Care Economics Should Keep Improving Going Forward
InnovAge's earnings could accelerate as it fills existing centers and controls care costs, turning enrollment growth into faster profit growth. However, slower reimbursement growth in coming quarters ...
Breaking News
View All →Featured Articles
Top Headlines
Stock News•20 minutes ago
House G.O.P. Leaders Ask Nvidia's Huang to Speak in Closed-Door Briefing
Stock News•1 hour ago
Stock Market Today, Nov. 5: Amazon Shares Slide as Technology Selloff Erases Early Gains
Stock News•1 hour ago
Google, Meta and TikTok Sue California Over Ban on Features for Kids
Stock News•2 hours ago
Market Close: Stocks Tumble, Apple To Sell $7B In Debt, Wendy's Rejects Buyout Bid 11-5-2026
Stock News•2 hours ago